MedTrace Logo

HIV Risk and Prevention in Women

NCT02263391 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2017-02-23

No results posted yet for this study

Summary

This study gathers information about HIV testing utilization and influences on HIV testing decisions among young, general population Russian women at-risk of HIV exposure. The study compares HIV testing acceptance across two types of low-barrier testing strategies (opt-in vs. opt-out) and conducts one of the first randomized experimental comparisons of these strategies. The overarching goal is to gain knowledge that can be used to increase utilization of HIV testing among at-risk young women and offer gender-specific strategies for improving prevention.

Conditions

Interventions

BEHAVIORAL

Opt-in or Opt-out testing

Study participants will be offered a health screening onsite.

BEHAVIORAL

Focus Group

Study participants will be invited to participate in a focus group discussion.

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    collaborator NIH

  • Russian Foundation for Basic Research (RFBR)

    collaborator UNKNOWN

  • Saint Petersburg State University, Russia

    collaborator OTHER

  • University of Oklahoma

    lead OTHER

Principal Investigators

  • Tatiana Balachova, PhD · University of Oklahoma

  • Alla Shaboltas, PhD · Facility: St. Petersburg State University St. Peterburg, Russian Federation

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
44 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • United States
  • Russia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02263391 on ClinicalTrials.gov